Instrument Inactif

Communiqués MYnd Analytics Inc Nasdaq

Actions

US62857N2027

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Emmaus Life Sciences : Certificate of Incorporation/Bylaws - Form 8-K	28/05	PU
Emmaus Life Sciences Reports Delayed Filing of Annual Report	15/04	PR
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico	02/02	PR
Emmaus Life Sciences : Material Agreement - Form 8-K	20/12	PU
Emmaus Life Sciences Reports Q3 2023 Financial Results	14/11	PR
Emmaus Life Sciences Reports Management Changes	23/08/23	PR
Emmaus Life Sciences Reports Q2 2023 Financial Results	14/08/23	PR
Emmaus Life Sciences : Reports Q2 2023 Financial Results - Form 8-K	14/08/23	PU
Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman	13/07/23	PR
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA	31/05/23	PR
Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update	15/05/23	PR
Emmaus Life Sciences Provides Interim Shipment Data	03/04/23	PR
Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update	31/03/23	PR
EMMAUS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/23	AQ
Emmaus Life Sciences : Private Placement - Form 8-K	07/03/23	PU
EMMAUS LIFE SCIENCES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	07/03/23	AQ
Emmaus Life Sciences : Private Placement - Form 8-K	19/01/23	PU
EMMAUS LIFE SCIENCES, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	19/01/23	AQ
Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari®	19/12/22	PR
Emmaus Life Sciences : Submission of Matters to a Vote of Security Holders - Form 8-K	12/12/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués MYnd Analytics Inc Nasdaq

Actions

US62857N2027

Communiqués

Filtres